Opendata, web and dolomites

FibroFix SIGNED

FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FibroFix project word cloud

Explore the words cloud of the FibroFix project. It provides you a very rough idea of what is the project "FibroFix" about.

drawbacks    stiffness    biostable    biocompatible    injuries    function    seeking    resurfacing    prevention    recourse    regeneration    paradigm    rehabilitation    trade    supports    potentially    additional    clinical    productivity    lubricious    resilient    health    pain    country    innovative    combination    frequent    grant    deterioration    chronic    13m    finance    mobility    orthopaedic    smooth    repair    disease    rubbing    unmet    almost    public    characterised    ultimate    11    joint    tkr    lesions    prolonged    quality    investment    bones    minimum    burdens    shifting    orthopaedics    involve    severe    half    inefficient    effectiveness    ing    orthox    led    life    osteoarthritic    disability    solutions    times    worldwide    postponement    cartilage    hospitalizations    heart    expensive    durable    ratio    regenerative    25m    economic    replacement    prevalence    knee    decreased    complications    fibrofix    osteoarthritis    treatments    biomaterials    oa    round    pressing    lengthy    solution    emulates    total    articular    treatment   

Project "FibroFix" data sheet

The following table provides information about the project.

Coordinator
ORTHOX LIMITED 

Organization address
address: 66 INNOVATION DRIVE MILTON PARK
city: ABINGDON
postcode: OX14 4RQ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.orthox.co.uk/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ORTHOX LIMITED UK (ABINGDON) coordinator 50˙000.00

Map

 Project objective

Cartilage deterioration and injuries often lead to osteoarthritis (OA) – a long-term chronic disease resulting in bones rubbing together and creating pain, stiffness and severe disability. Knee cartilage injuries are very common and almost half of them go on to develop OA, which is second only to heart disease as a cause of work disability. Resulting from decreased quality of life, hospitalizations and loss of productivity, the economic cost of OA is particularly high in every country that it has been estimated. Currently, all treatments available, including Total Knee joint Replacement (TKR) as the ultimate recourse, are inefficient and expensive: they involve pain, lengthy rehabilitation, frequent complications and high costs. Therefore, given the increasing prevalence of knee OA, its associated burdens and the drawbacks of all available treatments, it is becoming increasingly important to develop an innovative cost-effective solution to this major public health problem worldwide.

FibroFix™ Cartilage is a well characterised, regenerative orthopaedic repair product to address the unmet and pressing clinical need of large and/or osteoarthritic articular cartilage lesions in the knee, developed by Orthox. It is biostable, biocompatible, emulates cartilage function and supports cartilage regeneration at the minimum cost effectiveness ratio. It allows resurfacing of large and/or potentially OA cartilage lesions, prolonged use of the joint, increased mobility, reduced pain and postponement or prevention of TKR. Smooth, robust, resilient, durable and lubricious, it is a unique combination to be applied in orthopaedics and biomaterials shifting the paradigm in knee OA treatment and up to 10 times less expensive than other solutions.

Over the previous 8 years, Orthox have led 11 major grant-funded programmes, raising more than €13M to finance product development. We are now seeking an additional €2.25M for the second investment round.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FIBROFIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FIBROFIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

Plasmanorg (2019)

Environmental-friendly organic chemical synthesis in plasma reactor

Read More